Effect of Ximelagatran and Warfarin on Stroke Subtypes in Atrial Fibrillation
Volume: 35, Issue: 2, Pages: 160 - 165
Published: May 1, 2008
Abstract
The most common stroke subtype among atrial fibrillation (AF) patients not receiving anticoagulants is cardioembolic. In the SPORTIF III and V trials, the oral direct thrombin inhibitor ximelagatran was as effective as warfarin in reducing the risk of stroke in patients with nonvalvular AF. We assessed any differential effect of warfarin versus ximelagatran on the risk and outcome of cardioembolic and noncardioembolic stroke.7329 patients with...
Paper Details
Title
Effect of Ximelagatran and Warfarin on Stroke Subtypes in Atrial Fibrillation
Published Date
May 1, 2008
Volume
35
Issue
2
Pages
160 - 165
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History